$3.07T
Total marketcap
$98.67B
Total volume
BTC 57.42%     ETH 11.69%
Dominance

Lyell Immunopharma LYEL Stock

$32.21   -10.646318%
Add to favorites
Market Cap
$684.31M
LOW - HIGH [24H]
$32.21 - $36.01
VOLUME [24H]
$57.63K
P/E Ratio
0
Earnings per share
-$22.75
Price   Prediction

Lyell Immunopharma Price Chart

Sorry, that's all we've gotfor now...

Lyell Immunopharma LYEL Financial and Trading Overview

Lyell Immunopharma stock price 32.21 USD
Previous Close 3.45 USD
Open 3.39 USD
Bid 0 USD x 1000
Ask 0 USD x 800
Day's Range 3.32 - 3.86 USD
52 Week Range 1.77 - 8.74 USD
Volume 2.19M USD
Avg. Volume 1.09M USD
Market Cap 963.49M USD
Beta (5Y Monthly) N/A
PE Ratio (TTM) N/A
EPS (TTM) -22.75 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 7.25 USD

LYEL Valuation Measures

Enterprise Value 315.02M USD
Trailing P/E N/A
Forward P/E -2.8175182
PEG Ratio (5 yr expected) 0.34
Price/Sales (ttm) 11.443562
Price/Book (mrq) 1.2292993
Enterprise Value/Revenue 3.742
Enterprise Value/EBITDA -1.943

Trading Information

Lyell Immunopharma Stock Price History

Beta (5Y Monthly) N/A
52-Week Change -29.30%
S&P500 52-Week Change 20.43%
52 Week High 8.74 USD
52 Week Low 1.77 USD
50-Day Moving Average 2.69 USD
200-Day Moving Average 3.93 USD

LYEL Share Statistics

Avg. Volume (3 month) 1.09M USD
Avg. Daily Volume (10-Days) 1.23M USD
Shares Outstanding 249.61M
Float 158.86M
Short Ratio 19.24
% Held by Insiders 15.72%
% Held by Institutions 68.18%
Shares Short 21.53M
Short % of Float 12.37%
Short % of Shares Outstanding 8.63%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin -216.084%
Operating Margin (ttm) -215.00000000000000000000000000000000%
Gross Margin 100.00%
EBITDA Margin -192.59%

Management Effectiveness

Return on Assets (ttm) -11.58%
Return on Equity (ttm) -21.85%

Income Statement

Revenue (ttm) 84.2M USD
Revenue Per Share (ttm) 0.34 USD
Quarterly Revenue Growth (yoy) -88.20%
Gross Profit (ttm) 84.68M USD
EBITDA -162159008 USD
Net Income Avi to Common (ttm) -181932992 USD
Diluted EPS (ttm) -0.85
Quarterly Earnings Growth (yoy) N/A

Balance Sheet

Total Cash (mrq) 612.77M USD
Total Cash Per Share (mrq) 2.46 USD
Total Debt (mrq) 66.64M USD
Total Debt/Equity (mrq) 8.5 USD
Current Ratio (mrq) 20.275
Book Value Per Share (mrq) 3.14

Cash Flow Statement

Operating Cash Flow (ttm) -167915008 USD
Levered Free Cash Flow (ttm) -50139876 USD

Profile of Lyell Immunopharma

Country United States
State CA
City South San Francisco
Address 201 Haskins Way
ZIP 94080
Phone 650 695 0677
Website https://www.lyell.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 274

Lyell Immunopharma, Inc., a clinical-stage cell therapy company, engages in developing T-cell reprogramming technologies for patients with solid tumors. It develops therapies using an ex vivo genetic reprogramming technologies, such as c-Jun overexpression and NR4A3 gene knockout, to endow resistance to T-cell exhaustion; and an ex vivo epigenetic reprogramming technologies, including Epi-R to generate population of T cells with durable stemness, and Stim-R, a proprietary synthetic cell mimetic. The company's pipeline includes LYL797, a genetically and epigenetically reprogrammed ROR1 chimeric antigen receptor (CAR) T-cell product candidate for the treatment of various solid tumors; LYL845, an epigenetically reprogrammed tumor-infiltrating lymphocytes product candidate that targets multiple solid tumors; LYL119, a CAR T-cell product candidate for enhanced cytotoxicity. The company was incorporated in 2018 and is headquartered in South San Francisco, California.

Q&A For Lyell Immunopharma Stock

What is a current LYEL stock price?

Lyell Immunopharma LYEL stock price today per share is 32.21 USD.

How to purchase Lyell Immunopharma stock?

You can buy LYEL shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Lyell Immunopharma?

The stock symbol or ticker of Lyell Immunopharma is LYEL.

Which industry does the Lyell Immunopharma company belong to?

The Lyell Immunopharma industry is Biotechnology.

How many shares does Lyell Immunopharma have in circulation?

The max supply of Lyell Immunopharma shares is 21.24M.

What is Lyell Immunopharma Price to Earnings Ratio (PE Ratio)?

Lyell Immunopharma PE Ratio is now.

What was Lyell Immunopharma earnings per share over the trailing 12 months (TTM)?

Lyell Immunopharma EPS is -22.75 USD over the trailing 12 months.

Which sector does the Lyell Immunopharma company belong to?

The Lyell Immunopharma sector is Healthcare.

Lyell Immunopharma LYEL included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
US Tech Composite IXIC 23464.01 USD
-0.04
3.63B USD 23426.78 USD 23521.05 USD 3.63B USD
US Tech US 700 Small Cap Index NQUS700SC 2645.34 USD
-0.24
2642.23 USD 2652.33 USD
US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG 3510.04 USD
-0.21
3505.44 USD 3518.91 USD
US Tech Biotechnology NBI 5705.93 USD
-1.05
5693.75 USD 5754.1 USD
US Tech Health Care IXHC 1187.53 USD
-0.86
1185.41 USD 1195.34 USD
US Tech Global Select Market Com NQGS 11500.69 USD
-0.03
11480.01 USD 11527.15 USD
Stlmt ID US Tech Biotechnology NBX 3995.9 USD
-4.37
4555.41 USD 4917.8 USD
✨New! Portfolio🚀